Vion Pharmaceuticals Reports 2009 First Quart...((Unaudited) Cash and cash equivalents...),Health
Navigation Links
Vion Pharmaceuticals Reports 2009 First Quarter Results
Date:5/11/2009
(Unaudited) Cash and cash equivalents $29,958 $37,990 Total assets 31,240 39,474 Convertible senior notes 54,156 55,443 Total liabilities 59,050 62,858 Shareholders' deficit (27,810) (23,384)
'/>"/>
| SOURCE Vion Pharmaceuticals, Inc. Copyright©2009 PR Newswire. All rights reserved |
Related medicine news :
1. Jiangbo Pharmaceuticals Announces New Ticker (JGBO) and CUSIP
2. Vanda Pharmaceuticals Announces Withdrawal of Director Nominees and Proposal to Liquidate Submitted by Tang Capital
3. Jazz Pharmaceuticals, Inc. Announces First Quarter 2009 Financial Results
4. Photos: Generic Pharmaceuticals Saved $734 Billion over Last Decade
5. VIA Pharmaceuticals Announces Positive Phase 2 Results of VIA-2291 in Cardiovascular Patients Using Serial MDCT Imaging of Coronary Plaque
6. Valeant Pharmaceuticals to Present at Bank of America and Merrill Lynch 2009 Health Care Conference
7. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter 2009 Financial Results on May 7, 2009
8. Watson Pharmaceuticals Reports First Quarter 2009 Results; Raises 2009 Outlook
9. Conference Call Advisory - NUCRYST Pharmaceuticals Corp. Conference Call to Discuss 2009 First Quarter Results
10. Endo Pharmaceuticals Reports First Quarter 2009 Financial Results
11. Ferring Pharmaceuticals and RESOLVE: The National Infertility Association Join Together to Launch Nurse Liaison Program
Post Your Comments:
(Date:11/7/2009)...,, WASHINGTON , Nov. 7 /PRNewswire-USNewswire...r today in support of H.R. 3962, the Affordable He... the legislation later tonight. Below are the Spe...e all know, is an historic moment for our nation a...eaders of every party and political philosophy -- ...
(Date:11/7/2009)...,, HOUSTON, Nov. 7 T...ented Lisa James, Director of Health at the Family...istinguished Service today at its semi-annual poli... Service is the highest honor the AMA House of Del... http://www.newscom.com/cgi-bin/prnh/20081209/AM...
(Date:11/7/2009)...,, HOUSTON, Nov. 7 Calling this...ciation (AMA), the AMA President J. James Rohack, ...physicians from all state and medical specialty so...licy-making meeting, where health system reform wi...om.com/cgi-bin/prnh/20081209/AMALOGO ) ,, "Ov...
(Date:11/7/2009)...,, WASHINGTON, Nov. 7 /PRNewswire-USNewswire/ -...earing, antichoice extremists are holding the enti...da. They are demanding that the bill go far beyond...been incorporated into the original bill. In an o... on early Saturday afternoon, antichoice Democrats...
(Date:11/7/2009)...,, WASHINGTON, Nov. 7 /PRNewswire-USNewswire/ -... House of Representatives to vote for the Stupak-E..., "The Stupak-Ellsworth-Pitts-Kaptur-Dahlkemper-Li...federal law on abortion funding and conscience pro... Act (H.R. 3962)," they said. ,, The letter was...
Breaking Medicine News(10 mins):Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 2Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 4Health News:AMA Honors Family Violence Prevention Expert 2Health News:AMA President Kicks Off AMA Meeting Focused on Health Reform 2Health News:Bishops Urge Passage of Stupak-Ellsworth Anti-Abortion Amendment for Health Reform Bill 2[0] Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention[0] AMA Honors Family Violence Prevention Expert[0] AMA President Kicks Off AMA Meeting Focused on Health Reform[0] Catholics for Choice Statement on Antiabortion Amendment to Healthcare Reform Bill[0] Bishops Urge Passage of Stupak-Ellsworth Anti-Abortion Amendment for Health Reform Bill
...s may fight MS, cancer and heart disease, studies ...ws) -- Caffeine, green tea and tart cherries may g...vascular troubles, respectively, new research sugg...San Diego. , Caffeine appears to help ward off mul...
...ole in the most serious healthcare settings, even ...fe care, according to research in the April issue ...anadian researchers spent nearly 300 hours observi...es. , They concluded that humour played an esse...
...08 Natural,Harmony Foods, Inc. (Pink Sheets: NHYF... at multiple upcoming shows., Show ...ional Show Dallas June 5-7 Healthy Li... Philadelphia July 20-23 Natural Products E...
...ing Concerns that Future Payment &, Coverage Pol...onoscopy Screening & Sedation...onal Coalition,for Quality Colorectal Cancer Scree...ctal cancer through educational programs,aimed at ...
...ple a day" Perhaps you should be. Adults who eat...cantly reduced risk of metabolic syndrome, a clust...chronic diseases such as diabetes and cardiovascul...ion data collected in the 1999-2004 National Healt...
...It,s common knowledge,that Americans suffer under ...Heart disease is the leading cause of death for me...staggering: one in two men and one in three,women ...ullet in preventing several cancers and,cardiovasc...
Other Medicine News:Health News:Food as Medicine? 2Health News:Food as Medicine? 3Health News:Food as Medicine? 4Health News:Humor plays an important role in healthcare even when patients are terminally ill 2Health News:Humor plays an important role in healthcare even when patients are terminally ill 3Health News:Natural Harmony Foods to Exhibit in Multiple Venues in '08 2Health News:Non-Profit Group Formed to Promote Safe Colorectal Cancer Screenings and Care: 2Health News:Non-Profit Group Formed to Promote Safe Colorectal Cancer Screenings and Care: 3Health News:Adults who eat apples, drink apple juice have lower risk for metabolic syndrome 2Health News:Dr. William S. Gruss, M.D., Says That Medical Research Shows You Can Reduce Your Risk of Cancer By Up To 77% and Reverse the Effects of Aging in A CARDIOLOGIST'S GUIDE TO ... ANTI-AGING, ANTIOXIDANTS & RESVERATROL 2Food as Medicine?Humor plays an important role in healthcare even when patients are terminally illNatural Harmony Foods to Exhibit in Multiple Venues in '08Non-Profit Group Formed to Promote Safe Colorectal Cancer Screenings and Care:Adults who eat apples, drink apple juice have lower risk for metabolic syndromeDr. William S. Gruss, M.D., Says That Medical Research Shows You Can Reduce Your Risk of Cancer By Up To 77% and Reverse the Effects of Aging in A CARDIOLOGIST'S GUIDE TO ... ANTI-AGING, ANTIOXIDANTS & RESVERATROL
(Date:11/6/2009)..., Nov. 6 Caraco Pharmace...aunched ketorolac tromethamine ophthalmic solution... and Drug Administration (FDA) for Sun Pharma,s Ab...Acular® opthalmic solution on the first day f...olac is therapeutically equivalent to Acular®...
(Date:11/6/2009)...IS, November 6 , - Trial ...lid for the,Treatment of Multi-Resistant Staphyloc... a speciality pharmaceutical company focused on th...esigned to overcome the significant global,problem... most advanced oral,antibacterial NXL103 (floprist...
(Date:11/5/2009)...GO, Nov. 5 Althea Technologies, I...turing services for biopharmaceutical products ann...lopment to the company,s platform of services, whi...es Matsuura, Director of Formulation Development. ...ion and analytical scientists, along with new labo...
Breaking Medicine Technology:Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 3Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 4Althea Technologies Adds Formulation Development to Its Integrated Offering of Contract Services 2Partnership to accelerate Trudeau Institute discoveries to patient care 8711 1Partnership to accelerate Trudeau Institute discoveries to patient care 8711 2Kidnapped Nonviolent Peaceforce Civilian Peacekeeper Released Unharmed 47816 1Kidnapped Nonviolent Peaceforce Civilian Peacekeeper Released Unharmed 47816 2Kidnapped Nonviolent Peaceforce Civilian Peacekeeper Released Unharmed 47816 3WWII Veterans Compete in National Veterans Golden Age Games 47813 1WWII Veterans Compete in National Veterans Golden Age Games 47813 2[0] Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution[0] Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI)[0] Althea Technologies Adds Formulation Development to Its Integrated Offering of Contract Services
...NTA, Dec. 11 The Arthritis Foundation,the leading...llion,Americans living with arthritis, today annou...eters of Enbrel (R) (etanercept), will be the,nati... (R)., "The Arthritis Foundation hosts hundreds o...to prevent, control and cure arthritis, the,nation...
...CETON, N.J. and FOSTER CITY, Calif., Dec. 11 /PRNe...(NYSE: BMY ) and Gilead Sciences, Inc.,(Nasdaq: ...ze ATRIPLA(R),(efavirenz 600 mg/emtricitabine 200 ... for the treatment of virologically suppressed adu... approval by the European,Commission. If approved,...
Other Medicine Technology:Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R) 2Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R) 3Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R) 4Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance to Include Commercialization of ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) in Europe 2Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance to Include Commercialization of ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) in Europe 3Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance to Include Commercialization of ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) in Europe 4Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance to Include Commercialization of ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) in Europe 5Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance to Include Commercialization of ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) in Europe 6Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance to Include Commercialization of ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) in Europe 7Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance to Include Commercialization of ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) in Europe 8Assay Development
Custom Conjugation
Iso-Electric Determination Kit
Rabbit Anti-Goat IgG (H & L) Antibody, Colloidal Gold Conjugated, 50 OD
Medicine Products:| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |